- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT02700061
Effects of Upper Limb Motor and Robotic Training Over Neuroplasticity and Function Capacity (NARLE1)
Effects of Upper Limb Motor Training and Upper Limb Robotic Training Over Neuroplasticity and Function Capacity: A Single-blind Randomized Clinical Trial With Patients With Stroke Sequelae
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
The trial is being carried out in the Institute of Physical Medicine and Rehabilitation of the University of São Paulo since February 2012. The investigators are including patients with clinical diagnosis of Ischemic or hemorrhagic stroke.
The patients are being randomized in blocks of four, six and eight, in two arms: ICT: patients are undergoing 60 minutes physiotherapy and occupational therapy twice a week for ten consecutive weeks. Other therapeutic services as phonoaudiology, psychology, nutrition, physical conditioning are prescribed upon the patients' medical demands. After the 10 weeks, the patients are undergoing two whole weeks of daily ICT as to reach 90% of the time under constraint, including weekends. During this last period, no other therapeutic service is offered, but the occupational therapy under ICT. Patients are not allowed to undergo robotic therapy.
Robotic therapy: patients are undergoing robotic occupational therapy for 60 minutes, three times a week for twelve consecutive weeks. All other therapeutic services are prescribed upon the patients' medical demands. Patients are not allowed to undergo ICT.
The investigator and the raters are blind to treatment.
The evaluations are done prior to the beginning of the treatment and at the end of it. The follow up assessments are done at 3 and 12 months after the end of the treatment.
The sample size was estimated to be 62 patients in each arm, a total size of 124 patients
Type d'étude
Inscription (Réel)
Phase
- Phase 2
Contacts et emplacements
Lieux d'étude
-
-
-
Sao Paulo, Brésil, 04116-040
- Centro de Pesquisa Clínica do Instituto de Medicina Física e Reabilitação do HCFMUSP
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Clinical diagnosis of stroke;
- Patients from 6 months after stroke up to 36 months after stroke;
- Clinically stable;
- Upper limb Brunnstrom scale III or IV;
- Brunnstrom scale above V if clinician supports patients will benefit from treatment;
- Minimum wrist extension of 20°, and minimum of 10° of metacarpophalangeal active extension.
- Signed Informed Consent Form;
Exclusion Criteria:
- Mini-Mental score lower than 20 points;
- Previous multiple strokes;
- Bone diseases and articulation injuries ;
- Presence of psychological disturbances capable of diminishing adherence;
- Articulation pain within the range of motion proposed by the therapies;
- Participation in another study protocol for upper limbs therapies.
- Previous treatment with robotic assisted therapies.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Seul
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Induced Constraint Therapy - ICT
Physical rehabilitation with Induced Constraint Therapy as part of the occupational therapy.
Standard Occupational Therapy two times a week for ten weeks, followed by two whole weeks of Induced Constraint Therapy.
|
Standard Occupational Therapy two times a week for ten weeks, followed by two whole weeks of Induced Constraint Therapy.
Autres noms:
|
|
Expérimental: Robotic occupational therapy
Physical rehabilitation with Robotic occupational therapy.
Robotic Occupational Therapy three times a week for twelve weeks.
|
Robotic Occupational Therapy three times a week for twelve weeks.
Autres noms:
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change on Motor Function assessed by Wolf Motor Function scale
Délai: Baseline and 12 weeks
|
Change from baseline in Wolf Motor Function scale.
|
Baseline and 12 weeks
|
|
Change on Motor Function assessed by Fugl Meyer scale
Délai: Baseline and 12 weeks
|
Change from baseline in Fugl Meyer scale.
|
Baseline and 12 weeks
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change on Motor Function assessed by Wolf Motor Function scale
Délai: Baseline, 3 months and 12 months
|
Multiple changes from baseline in Wolf Motor Function scale.
|
Baseline, 3 months and 12 months
|
|
Change on Motor Function assessed by Fugl Meyer scale
Délai: Baseline, 3 months and 12 months
|
Multiple changes from baseline in Fugl Meyer scale.
|
Baseline, 3 months and 12 months
|
|
Change on Motor Function assessed by Robotic scale
Délai: Baseline, 3 months and 12 months
|
Multiple changes from baseline in robotic scale.
|
Baseline, 3 months and 12 months
|
|
Change on Function ability and quality of movement assessed by Arm Motor Ability Test (AMAT)
Délai: Baseline, 12 weeks, 3 months and 12 months
|
Multiple changes from baseline in AMAT scale.
|
Baseline, 12 weeks, 3 months and 12 months
|
|
Change on Functional Independence Measure (FIM) as assessed by FIM scale
Délai: Baseline, 12 weeks, 3 months and 12 months
|
Multiple changes from baseline in FIM scale.
|
Baseline, 12 weeks, 3 months and 12 months
|
|
Change on Quality of life assessed by Stroke Impact Scale (SIS)
Délai: Baseline, 12 weeks, 3 months and 12 months
|
Multiple changes from baseline in SIS.
|
Baseline, 12 weeks, 3 months and 12 months
|
|
Change on Kinematic variables assessed by InMotion robots
Délai: Baseline, 12 weeks, 3 months and 12 months
|
Multiple motion changes from baseline in the Kinematic variables assessed by InMotion robots.
|
Baseline, 12 weeks, 3 months and 12 months
|
Autres mesures de résultats
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Psychological Evaluation assessed by Perceived Stress Scale (PSS-10)
Délai: Baseline, 12 weeks, 3 months and 12 months
|
Multiple changes from baseline in PSS-10.
|
Baseline, 12 weeks, 3 months and 12 months
|
|
Neuroplasticity as assessed by Brain Derived Neurotrophic Factor (BDNF)
Délai: Baseline, 12 weeks, 3 months and 12 months
|
Multiple changes from baseline in BDNF.
|
Baseline, 12 weeks, 3 months and 12 months
|
|
Corticospinal excitability as assessed by transcranial magnetic stimulation (TMS)
Délai: Baseline, 12 weeks, 3 months and 12 months
|
Multiple changes from baseline in TMS.
|
Baseline, 12 weeks, 3 months and 12 months
|
|
Neurologic evaluation as assessed by electroencephalography
Délai: Baseline, 12 weeks, 3 months and 12 months
|
Multiple changes from baseline in electroencephalography.
|
Baseline, 12 weeks, 3 months and 12 months
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Linamara Rizzo Battistella, Md PhD, University of Sao Paulo
Publications et liens utiles
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude
Achèvement primaire (Anticipé)
Achèvement de l'étude (Anticipé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Estimation)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- 0910.0.015.000-11
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .